- 02:28 PM Hold Hyderabad Industries: Irani
- 02:21 PM Lodha Developers hopes to launch IPO in Dec
- 02:14 PM Hold Shree Renuka Sugar: Gujral
- 02:09 PM Sensex rallies over 1.5% led by metals, IT, cap go...
- 02:02 PM Keep Rs 440 stoploss in NMDC: Gujral
- 01:57 PM Oct car sales rise fastest in over 2 years
- 01:52 PM Delta Corp has target of Rs 65: Irani
- 01:48 PM Ex-Bear Stearns hedge fund managers acquitted
- 01:44 PM Jyothy Laboratories a safe bet: Irani
- 12:58 PM Cyclone Phyan to bring heavy rains to Mumbai



Broking house, Angel Broking expects that Ranbaxy Laboratories is to post net sales of Rs 1,428 crore (Rs 14.28 billion), up 11.3% and net profit of Rs 156 crore (Rs 1.56 billion), up 734.8% in Q2FY07. Its operating profit margin is to be seen at 16.9%. The earnings for FY07 are likely to be at Rs 15.5 per share.
It is confident about Ranbaxy and has recommended hold rating on the stock.
|
Also Read
RSS feed for news about this stock Click here |
Outlook on Pharmaceutical Sector
The report says, “For Q2FY2007, large Indian Pharmaceutical companies especially Ranbaxy and DRL are expected declare a robust performance. Simvastatin (Ranbaxy and DRL) and Finasteride would be the key growth drivers. These products, which were launched towards the fag end of June'06, would reflect fully during Q2FY2007 aiding robust performance by these companies. On the other hand, the Midcap Indian Pharma segment will post a mixed set of numbers, while performance of the MNC Pharmaceutical space is expected to be lackluster.”
“From an investment perspective, given the competitive scenario in the generic space and opportunities in the CRAMS segment, we recommend investment in the CRAMS segment. Our top picks in the sector are Cadila Healthcare, NPIL, Wockhardt, Shasun Chemicals, JUBL and Marksans Pharmaceutical.”
|
|


Today's Special Column
with Pronab Sen
Union Ministry of Statistics and Programme Implementation , Chief Statistician and Secretary


-
Most Read
-
Most Viewed
- 10 companies that MF managers love
- 10 Companies that FIIs love
- Mitesh Thacker's top picks for today's trade

- Experts on stocks and sectors to pick/avoid now

- Ganeshaspeaks: Market prediction for Nov 11
- IPO scam: SEBI bars Pyramid Saimira for 7 years

- How greed got the better of this Morgan Stanley star
- RIL readying $25bn for global acquisitions: Sources
- Hold Hyderabad Industries: Irani
Source: CNBC-TV18
- Hold Shree Renuka Sugar: Gujral
Source: CNBC-TV18
- Sensex rallies over 1.5% led by metals, IT, cap goods, RIL
Source: Moneycontrol.com
- Keep Rs 440 stoploss in NMDC: Gujral
Source: CNBC-TV18
- NMDC, AP body to enter mining pact
Source: Business Line
- Volvo-Eicher semi low-floor buses to hit the roads next yr
Source: Business Line
- Petronet likely to award LNG jetty contract next month
Source: Business Line
- NTPC units shut down on coal shortage
Source: Business Line





















